Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05322070 · ClinicalTrials.gov registry record · Phase 4
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
A Phase 4 study of Uveitis, Posterior, sponsored by Alimera Sciences.
- Active
- Registry status
- Phase 4
- Development phase
- 125
- Enrollment target
- 20
- Study locations
NCT05322070 is a Phase 4 study of Uveitis, Posterior that is active but no longer recruiting, run by Alimera Sciences. The registered enrollment target is 125 participants, below the 139-participant average among 6 other Uveitis, Posterior trials with a reported enrollment target (10% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT05322070, a Phase 4 study of Uveitis, Posterior, is active but no longer recruiting, sponsored by Alimera Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 125 participants
- Enrollment target
- 20
- Study locations
Study Summary
A study to evaluate the safety and efficacy of YUTIQ® 0.18 mg intravitreal implant for the management of chronic non-infectious posterior segment uveitis (intraocular inflammation) that has responded to previous steroid therapy.
Conditions Studied
Interventions
- DRUG Fluocinolone Acetonide Intravitreal Implant 0.18 mg
Study Locations (20)
California
- Retina Consultants of Orange County - Fullerton
- Macula and Retina Institute - Glendale
- California Eye Specialists Medical Group - Pasadena
- Retinal Consultants Medical Group - Sacramento
Florida
- Advanced Research - Coral Springs
- Retina Specialists of Tampa - Wesley Chapel
Illinois
- Retinal Vitreal Consultants Ltd. - Chicago
- Illinois Retina Associates, S.C. - Oak Park
Massachusetts
- Opthalmic Consultants of Boston - Boston
- Massachusets Eye Research and Surgery Institution - Waltham
Colorado
- Retina Associates of Colorado - Lakewood
Georgia
- Marietta Eye Clinic - Marietta
Maryland
- Cumberland Valley Retina Consultants - Hagerstown
Michigan
- Foundation for Vision Research - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2025-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05322070
The ClinicalTrials.gov registry entry for NCT05322070 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 139-participant average among 6 other Uveitis, Posterior trials with a reported enrollment target (10% lower). The listed sponsor is Alimera Sciences, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uveitis, Posterior appearing as the primary indexed condition, and to 1 intervention - of which Fluocinolone Acetonide Intravitreal Implant 0.18 mg is the first listed.
NCT05322070 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT05322070 about?
NCT05322070 is a clinical study titled "Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis". A study to evaluate the safety and efficacy of YUTIQ® 0.18 mg intravitreal implant for the management of chronic non-infectious posterior segment uveitis (intraocular inflammation) that has responded to previous steroid therapy.
What is the current status of trial NCT05322070?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 125 participants. The study started on 2022-06-06. Estimated completion is 2025-11.
What conditions does trial NCT05322070 study?
This clinical trial studies the following conditions: Uveitis, Posterior.
What interventions are being tested in trial NCT05322070?
The interventions under investigation include: Fluocinolone Acetonide Intravitreal Implant 0.18 mg (DRUG).
Who is sponsoring clinical trial NCT05322070?
This trial is sponsored by Alimera Sciences, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05322070 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uveitis, Posterior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
RECRUITING · Phase 3
-
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
ACTIVE NOT RECRUITING · Phase 3
-
Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
COMPLETED · Phase 3
-
MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
COMPLETED
-
A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
COMPLETED · Phase 3
-
Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.